High materiality7/10
Myriad Genetics price target raised to $8 from $4 at Craig-Hallum
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
bullish
What happened, with direct paths to the underlying reporting
Analyst target update: target raised to $8 from $4; current price around $4.30; priceChangeSinceSignal +0.35.
Target: $8
Posted price: $4.3
Analyst firm: Craig-Hallum
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.